Eric van der Putten | Partner

Eric's 30 years of clinical research experience derives from the Comprehensive Cancer Center where he started his career in 1983 as head trial department. Between 1990 and 2007 he held several positions at companies specialized in clinical research including NDDO Oncology, where he acted as COO and CEO. After INC Research aquired NDDO Oncology in 2005, Eric became Vice President Oncology for Europe of INC Research. Eric is co-founder of SMS-oncology, a specialized oncology CRO established in 2007 where he worked as COO and CEO. In 2013 he became partner at Aglaia. Eric is director at Modra Pharmaceuticals and non-executive director at Mimetas.